Form 4: Director Ross Acquires Shares of LeMaitre Vascular Through PSU Settlement

Director Bridget A. Ross acquired shares of LeMaitre Vascular common stock through the settlement of a Performance Share Unit (PSU) award and release of dividend equivalent rights on February 29, 2024.

Summary

• On February 29, 2024, Bridget A. Ross, a director of LeMaitre Vascular, Inc. (LMAT), acquired 593 shares of common stock upon the settlement of a Performance Share Unit (PSU) award.
• The PSU award was granted on December 12, 2022, and vests in installments.
• Ross also acquired 1 share upon the release of dividend equivalent rights.
• The price for the shares acquired through PSU settlement and dividend equivalent rights was $0.
• Following these transactions, Ross directly owns 2,278 shares of LeMaitre Vascular common stock.
• These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022.
• Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The director's acquisition of shares could be interpreted slightly positively, but it's primarily a procedural disclosure.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals insider confidence.

Key Dates